Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41628334.
- Also identified by DOI 10.1073/pnas.2515002123 and PMC identifier 12890929.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tyrosine nitration alters the structure, function, and cellular localization of proteins and is implicated in the pathology of multiple diseases [G. Ferrer-Sueta <i>et al.</i>, <i>Chem. Rev.</i> <b>118</b>, 1338-1408 (2018), H. Ischiropoulos, <i>Arch. Biochem. Biophys.</i> <b>356</b>, 1-11 (1998), I. Griswold-Prenner <i>et al.</i>, <i>J. Biol. Chem.</i> <b>299</b>, 105038-10554 (2023)]. Although protein nitration is assumed to proceed via nonspecific chemical mechanisms, it is highly selective, suggesting the possibility of enzymatic catalysis. Here, we showed that glyoxalase domain-containing protein 4 (GLOD4), a previously uncharacterized protein, is an enzyme that catalyzes selective protein nitration. A primary in vivo target for GLOD4-mediated nitration is alpha-synuclein (α-syn), which is central to the pathogenesis of Parkinson's disease (PD) and related disorders. We document tyrosine nitration of α-syn by GLOD4 in vitro, in cells, and in a murine model of synuclein pathology. The data identified a function of GLOD4 and other structurally related proteins that catalyze the peroxynitrite-mediated selective protein tyrosine nitration. This enzymatic catalysis of nitration may unearth pathophysiological mechanisms and potential interventions in diseases such as PD, cancer, and autoimmunity.
Medical subject headings
- Peroxynitrous Acid
- Neoplasm Proteins
- alpha-Synuclein
- Tyrosine
- Parkinson Disease, Secondary